Pharmalot By Ed Silverman A failed Valeant battlecry: ‘We’re not like Turing in any way, shape or form’
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: China probing drug and device makers for antitrust violations
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Price increases on biologics diminish savings on biosimilars
Pharmalot By Ed Silverman Hospitals remain skeptical about Valeant discounts on important heart drugs
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Valeant CEO says he was too aggressive in raising drug prices
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Ackman to testify at Senate hearing on drug prices
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Valeant looks to sign Perrigo chief as its new CEO
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Little company makes big bet on discarded Roche drug